I see a few posters seem to think KZA has already been awarded 2 PRVs which the company could sell any time now.
That is incorrect. We have 2 RPD designations for PAX. We only get a voucher if PAX is FIRST approved in the indication. So still years away yet.
We currently have no PRVs.
We will never receive more than 1 PRV for PAX, we just have 2 separate opportunities.
Given that GBM will likely be our first disease indication submitted for FDA approval making PAX ineligible for PRV, it is unlikely we will never get a PRV for PAX.
KZA Price at posting:
62.0¢ Sentiment: Buy Disclosure: Held